Welcome to our dedicated page for Fonar SEC filings (Ticker: FONR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Fonar Corporation revolutionized diagnostic imaging with the first upright MRI, and its SEC filings continue to reveal how that innovation translates into revenue from both scanner sales and a nationwide network of imaging centers. Each document holds clues about scan volumes, reimbursement trends, and service contracts that drive cash flow—information too important to leave buried in footnotes.
Need the latest Fonar quarterly earnings report 10-Q filing or want to review Fonar insider trading Form 4 transactions? Stock Titan delivers Fonar SEC filings explained simply. Our AI reads every page, highlights segment margins, flags FDA-related disclosures from 8-Ks, and converts technical language into clear takeaways. You’ll understand scan-volume growth without wading through medical jargon.
Real-time alerts mean Fonar Form 4 insider transactions real-time hit your dashboard seconds after EDGAR posts. From a Fonar annual report 10-K simplified to a concise Fonar proxy statement executive compensation summary, every filing arrives fully annotated. Even market-moving notices get the Fonar 8-K material events explained treatment, complete with context and historical comparisons.
- AI-powered summaries surface reimbursement and scan-volume insights
- Instant alerts for Fonar executive stock transactions Form 4
- Side-by-side Fonar earnings report filing analysis across quarters
- Searchable archive for understanding Fonar SEC documents with AI
Spend less time parsing filings and more time modeling how Fonar’s breakthrough MRI technology drives long-term value.
FONAR Corporation (Form 10-K) reported consolidated financial and operational details for fiscal 2025, highlighting its continued majority ownership of Health Diagnostics Management (HDM) and material credit reserving. The company sold a non-controlling interest for $132,000, leaving a direct HDM ownership of 70.63% and investors with 29.37%. Management tested internal controls over patient fee revenue, CECL estimates and IT general controls for its billing systems.
The filing discloses an allowance for credit losses of $4,366,000, recorded valuation allowances against state net operating losses, and detailed share activity including repurchases: the company repurchased 114,588 shares at a cost of $1,806,646 and cancelled 124,829 shares valued at $1,963,385. The company derives a large portion of revenues from no-fault and personal injury protection (about 67% of net revenues).
Money Concepts Capital Corp reported owning 462,760 shares of FONAR Corp common stock, representing 7.5% of the class. The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
The filer reports sole dispositive power over 462,760 shares and no voting power (sole or shared). The Schedule 13G/A identifies the filers principal office in Palm Beach Gardens, Florida, and lists the issuers principal executive office in Melville, New York.
Renaissance Technologies reports a 5.09% stake in Fonar Corporation, representing 315,516 shares held with sole voting and dispositive power. That level of ownership makes Renaissance a material minority investor but the filing states the shares are held in the ordinary course of business and not for the purpose of changing or influencing control.
Two related entities—Renaissance Technologies LLC (an investment adviser) and Renaissance Technologies Holdings Corporation (a holding company)—report identical ownership and note that certain funds they manage have the right to receive dividends or sale proceeds from these shares.
Kayne Anderson Rudnick Investment Management, LLC reports beneficial ownership of 544,036 shares of Fonar Corp ordinary stock, representing 8.8% of the class. The filer indicates sole voting power and sole dispositive power over all reported shares. The statement is filed as a Schedule 13G amendment and the filer certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The filing lists the reporting person as an investment adviser (Type IA) and notes no shared power or group affiliation.
Fonar Corporation (Nasdaq: FONR) filed a Form 8-K on June 23, 2025 to disclose a governance change under Item 5.02. Claudette J.V. Chan, a member of the Board of Directors and the Company’s Secretary, notified the Company of her intention to retire effective June 19, 2025. The filing explicitly states that Ms. Chan cited no disagreements with the Company’s operations, policies, or practices. No successor appointments, financial updates, or additional corporate actions were included in the report.
President & CEO Timothy R. Damadian signed the filing, confirming compliance with SEC disclosure requirements. Aside from the routine leadership transition, the 8-K contains no material financial data or strategic changes.
FAQ
What is the current stock price of Fonar (FONR)?
What is the market cap of Fonar (FONR)?
